![Mark Parry-Billings](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Parry-Billings
Vorsitzender bei
SYNAIRGEN PLC
Profil
Mark Parry-Billings is Executive Chairman at Synairgen Plc starting in 2025.
Former roles include Chief Executive Officer at Topigen Pharmaceuticals, Inc. from 2007 to 2010, Chairman at Zymenex A, Director at Innovata Biomed Ltd., Director at pSiMedica Ltd., Principal at Schering Health Care Ltd., and Head-Corporate Drug Development at CHIESI Farmaceutici SpA. Education includes a doctorate from the University of Oxford.
Aktive Positionen von Mark Parry-Billings
| Unternehmen | Position | Beginn |
|---|---|---|
| SYNAIRGEN PLC | Vorsitzender | 10.10.2024 |
Ehemalige bekannte Positionen von Mark Parry-Billings
| Unternehmen | Position | Ende |
|---|---|---|
Topigen Pharmaceuticals, Inc.
 Topigen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for respiratory diseases | Vorstandsvorsitzender | 01.01.2010 |
CHIESI Farmaceutici SpA
 CHIESI Farmaceutici SpA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and markets respiratory health, rare diseases and specialty care products | Corporate Officer/Principal | - |
Zymenex A/S
 Zymenex A/S BiotechnologyHealth Technology Engages in the research and development of therapeutics for life threatening diseases | Vorsitzender | - |
Schering Health Care Ltd. | Corporate Officer/Principal | - |
Innovata Biomed Ltd.
 Innovata Biomed Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in the research, development, and commercialization of respiratory drug delivery technologies | Direktor/Vorstandsmitglied | - |
Ausbildung von Mark Parry-Billings
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
21
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Schering Health Care Ltd. | |
Synairgen Plc
 Synairgen Plc Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for respiratory disorders | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CHIESI Farmaceutici SpA
CHIESI Farmaceutici SpA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and markets respiratory health, rare diseases and specialty care products | Health Technology |
Innovata Biomed Ltd.
Innovata Biomed Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in the research, development, and commercialization of respiratory drug delivery technologies | Commercial Services |
pSiMedica Ltd.
 pSiMedica Ltd. Miscellaneous Commercial ServicesCommercial Services Researches and develops nanostructured porous silicon | Commercial Services |
Zymenex A/S
Zymenex A/S BiotechnologyHealth Technology Engages in the research and development of therapeutics for life threatening diseases | Health Technology |
Topigen Pharmaceuticals, Inc.
Topigen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for respiratory diseases | Health Technology |
